Close Menu

Lung Cancer

News and reporting on lung cancer.

NEW YORK (GenomeWeb News) – Med BioGene today announced it has amended its commercialization agreement with Precision Therapeutics for Med Bio's LungExpress Dx test.

NEW YORK (GenomeWeb News) – The University of Texas MD Anderson Cancer Center on Thursday announced a major initiative that includes genomics components to accelerate scientific discovery into clinical advances in order to reduce the number of cancer deaths.

In the most comprehensive genomic study to date of lung squamous cell carcinoma, researchers affiliated with the Cancer Genome Atlas project have identified potential drug targets in more than two-thirds of the 178 tumors sequenced, highlighting potential treatment options to a t

Two independent teams have sequenced small-cell lung cancer exomes and transcriptomes, identifying several potential therapeutic leads.

Researchers from the Wistar Institute are using a $1 million grant from Pennsylvania's Commonwealth Universal Research Enhancement Program to develop a gene expression-based blood test to detect early-stage lung cancer.

NEW YORK (GenomeWeb News) – Investigators at the Wistar Institute have received a $1 million grant from Pennsylvania’s Commonwealth Universal Research Enhancement (CURE) program to fund a partnership with the Christiana Care Health System and Temple University Health System to develop a diagnosti

NEW YORK (GenomeWeb News) – Epic Sciences, which is developing diagnostics to identify and characterize rare cells, said today it is collaborating with six drug manufacturers to develop companion diagnostic tools.

The headline for this story has been updated from a previous version to clarify that the company has completed enrollment for the trial.

Caprion Proteomics aims next year to open a CLIA lab for protein biomarker-based diagnostics, several of which will likely be run on a mass spec platform, a company official told ProteoMonitor this week.

Opko Health last week presented data at the Alzheimer's Association International Conference in Vancouver demonstrating that its antibody-based Alzheimer's diagnostic identified cases of the disease with 100 percent specificity in a set of 36 autopsy-confirmed plasma samples.

Pages

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.